Blood biomarker pTau217 flags Alzheimer's risk years before symptoms
TL;DR Summary
A Mass General Brigham-led study shows a blood test measuring pTau217 can predict Alzheimer's risk years before symptoms appear, potentially enabling earlier, less invasive screening than PET scans; while promising, more research is needed to validate across diverse populations and translate these findings into clinical practice.
- Blood Test Could Predict Alzheimer’s Risk Long Before Symptoms Surface, Paving the Way for Early Detection Indian Defence Review
- Blood Tests Could Reveal Alzheimer's Risk Years Before Symptoms Appear ScienceAlert
- New Blood Test May Predict Dementia Years Earlier by Analyzing Gut Health, Scientists Say EatingWell
- Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adults Nature
- Enhance Neurodegenerative Detection and Monitoring with BD-pTau 217 and α-Syn, Upcoming Webinar Hosted by Xtalks PR Newswire
Reading Insights
Total Reads
0
Unique Readers
3
Time Saved
7 min
vs 7 min read
Condensed
97%
1,374 → 46 words
Want the full story? Read the original article
Read on Indian Defence Review